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Abstract: Infertility rate documented in Pakistan is 21.9% with only 25% success rate even after procedures like 
intracytoplasmic sperm injection (ICSI). This rate is further on the decline with enhancement of female age. We aimed to 
observe the effect of female age on oocyte parameters and reproductive outcome after ICSI. It was done by retrospective 
analysis of a quasi- experimental design carried out after approval from “Ethical review board of Islamabad clinic 
serving infertile couples” from July 2010 to August 2011. The response to ovarian stimulation in (282) females was 
assessed on the basis of groups, A, B, C and D with age ranges up to 25years; 25.1 to 30years; 30.1 to 35years and 
>35years, respectively. The outcome was assessed as non-pregnant, preclinical abortion and clinical pregnancy groups 
on the basis of beta hCG and cardiac activity by trans-vaginal scan. We observed that maximum number of pregnancies 
32 (38%) occurred in C group, and least 10 (10%) in group A. There was a statistical reduction in the number of mature 
and fertilized oocytes as the age advanced from group C to D (p<0.05).This shows that reduction in maturity and 
fertilization of oocytes with advancement of age recommends early referral of couples to assisted reproductive clinics. 
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INTRODUCTION 
 
Infertility can be defined as incapability of a couple to 
enjoy parenthood after unprotected regular intercourse 
without any contraception over a period of at least 1-2 
years (Rehman et al., 2015). Intracytoplasmic sperm 
injection (ICSI) developed especially for treatment of 
sterile couples is an infertility treatment in which a sperm 
is directly injected in the oocyte (Spandorfer et al., 1998, 
Rehman et al., 2014). The procedure deals with in fecund 
males and also women of variable age groups and 
repeated failures after in-vitro fertilization (IVF) (Palermo 
GD et al., 1995). ICSI has resulted in exponential rise in 
the number of children born as a result of infertility 
treatment plans (Wong and Ledger, 2013).  
 
There is a decline in reproductive functions, ovarian 
reserve and its response to stimulation with the 
enhancement of maternal age
 
(Marca et al., 2011). The 
mean age of women carrying their first child has 
increased up to 5years due to a number of factors 
including delay in marriages, contraception, and reliance 
of assortment to assisted reproductive technology (ART). 
Female fertility progresses to a rapid decline after the age 
of 35 even after assisted reproductive techniques (ART) 
(Baird et al., 2005).  Advancing age deleteriously causes a 
diminution in ovarian reserve (OR) with a decrease in 
number and quality of oocyte, hormones of implantation, 
fertilization rate and success after ICSI (Rehman et al., 
2015 b). The effect of increasing maternal age on fertility 
is attributed to poor oocyte parameters that decrease 
pregnancy rate and multiplies risk of chromosomal 
abnormalities in the embryo (Kim et al., 2013). 
 
The association of maternal age and fertility documented 
by Hutterites declared that maximum infertility occurred 
after 35 years of age
 
(Hassold et al., 2009). In another 
investigation, there was a significant effect of female age 
on pregnancy rate and age group of 19-26 year old 
women had a higher number of pregnancies as compared 
to women belonging to 27-29year old group (Dunson and 
Baird, 2004). There was one-sixth the number of 
pregnancies in women above 40years of age as compared 
to women aged less than 34years (Oehniger et al., 1995). 
Since there is lack of available data on effect of female 
age on outcome after ICSI, we aimed to investigate the 
effects of maternal age on oocyte parameters and 
reproductive outcome after ICSI. 
 
MATERIALS AND METHODS  
 
It was a retrospective analysis of a quasi-experimental 
study conducted after approval from the Ethical Review 
Board of “Islamabad Clinic Serving Infertile Couples” 
from June 2010 till August 2011. Data of 282 females 
with age 18-41 years, infertility duration of more than 2 
years, body mass index (BMI) of 18-27kg/m
2
and both 
functional ovaries exhibiting cycle of 25-35 days with 
basal serum FSH level <10IU/mL was collected. Females 
with metabolic and endocrine abnormalities, uterine 
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fibroids and previous failed attempts of ICSI were 
excluded. 
 
Treatment protocol 
All subjects were given long desensitizing protocol for 
mid luteal pituitary down regulation of ovaries by 
subcutaneous administration of GnRHa Decapeptyl 3.75 
mg depot or Decapeptyl 0.1mg daily from D-21 of the 
preceding cycle. Controlled Ovarian Stimulation was 
carried out by using subcutaneous administration of 
recombinant FSH (r FSH) 50IU preparation (Puregon 
registered; NV Organon, Oss, The Netherlands). The 
initiation dose was calculated on the basis of age of the 
subject, basal serum FSH concentrations, AFC and BMI. 
Dose adjustment was performed by follicular tracking 
with trans vaginal scan TVS (7.5MHz probe Aloka 500, 
Tokyo Japan) that commenced from the fifth day of COS 
on alternate days for assessment of follicular response and 
measurement of endometrial thickness. Ovulation 
Induction (OI) was decided on the basis of maximum 
number of follicles > 18±2mm in diameter on TVS 
(around 14±2 days of COS). It was made possible by 
administration of human chorionic gonadotrophin (hCG) 
by intra muscular injection of 10,000IU of hCG 
(Profasi®, Serono, Switzerland). On the day of OI 
(dhCG) venous sample was taken for initial estradiol 
(E2), and Progesterone (P) estimation (Endometrial 
thickness was measured by experienced sonographers in 
the midsagittal plane on the day of OI by two-dimensional 
ultrasound with a 7.5-MHz probe (Hitachi EUB 525; 
Hitachi, Tokyo). Oocytes were retrieved 36 hours after OI 
on 14th, 15th or 16th day of COS by vaginal ultrasound 
probe with 16G adapter and double lumen oocyte 
aspiration needle (Cook Australia; Queens land, 
Australia) under short general anesthesia. The follicle 
aspirate was immediately placed in to a 60mm labeled 
culture dish placed on a thermo plate at 37˚C (Falcon, 
Becton Dickinson and company, Franklin Lakes, USA) 
and examined under stero microscope (Leica MZ12; 
Wetzlar, Gernamy). They were then transferred into the 
culture dish containing culture medium GIVF Plus (Vitro 
life) overlaid with liquid paraffin oil (Ovoid virtolife, 
Tohai Hint Japan) preincubated at 37°C, 5% CO2. All 
oocytes were collected in a similar manner. Soon after the 
oocyte was found it was transferred to mini incubator (K-
MINC-1000, Australia). Sperm preparation for ICSI was 
made on the day of OPU after obtaining semen sample of 
husband in the clinic by masturbation following 3-5 days 
of abstinence. It was carried out using sperm Grad 
gradient (Vitro life) and preparations were kept in tri gas 
incubator (Sanyo MCO-18M- Germany). 
 
Micromanipulation  
ICSI was performed 3-6h after oocyte recovery on all 
morphologically intact eggs in Metaphase II stage. The 
procedure was carried out in labeled microinjection dish 
prepared by adding several 10ml droplets of G Gamete 
culture buffered media on the heated stage of an inverted 
phase contrast microscope under 200 x magnifications 
(Leica DMIRB, Leica Microsystems, Wetzlar, Germany) 
with the help of micro injection pipette. 
 
Assessment of fertilization and cleavage 
Fertilization was assessed 16-20 hours after ICSI. Only 
normally fertilized (with two pronuclei and two polar 
bodies) were considered for eventual embryo transfer. 
These were cultured for additional 24-30 hours at 37°C in 
fresh CO2 -equilibrated G1 Plus medium till cleavage, 
growth and differentiation of embryo. 
 
Assessment of embryo quality 
Embryos were evaluated on alternate days and were 
graded {Grades 1-5 from best to worst}. The degree of 
fragmentation was recognized as the embryonic volume 
occupied by enucleated cytoplasmic fragment 322RBM 
Online. 
 
Embryo transfer  
ET was carried out using Sure View Wallace- Embryo 
Replacement Catheter (SIMS-Porter Limited, Hythe Kent, 
UK) on Day-five or six after OPU under abdominal 
ultrasound guidance. In the procedure cervix was 
visualized with the help of a vaginal speculum, which was 
then cleansed with culture media. The optimal target for 
embryo replacement known as the maximal implantation 
potential was identified by abdominal scan. In the first 
step of ET, catheter was flushed with Embryo Glue 
(Vitrolife), shaped to the degree of angulation of cervix, 
loaded with embryos on its tip sand transferred under 
ultrasound guidance. 
 
Outcome measures 
The outcome of procedure was categorized into three 
groups on the basis of serum beta hCG measurement and 
TVS performed 14 and 28 days after egg collection 
respectively. Non-pregnant females had a negative beta 
hCG, preclinical abortion group had positive beta hCG 
without any cardiac activity on TVS and clinical 
pregnancy group included females who had confirmed 
pregnancy by appearance of cardiac activity on TVS. The 
outcome was studied in groups A; less than 25years, B; 
25. 1 till 30years, C; 30.1 till 35years and D; more than 
35years of female age respectively. Distribution of 
patients on the basis of age showed that A and B groups 
both comprised of 30% females whereas 11% and 29% 
had age up to 25years (A) and above 35years (D) 
respectively. 
 
STATISTICAL ANALYSIS 
 
Interpretation and analysis of data was done via SPSS 
(Statistical Packages of Social Sciences) version 15.0. 
Results of continuous variables are represented as mean ± 
standard deviation. Comparison of female age groups was 
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done by one way analysis of variance (ANOVA) with 
results declared significant at p-value <0.05. 
 
RESULTS 
 
Table 1 shows outcome of ICSI in 282 females out of 
which 162 conceived, 61 (60%) were biochemical and 
101 (36%) were clinical pregnancies. Maximum number 
of clinical pregnancies 42 (41%) was observed in 30.1-
35years (C) whereas least number 10 (10%) were 
observed in less than 25years age group (A). Group D 
(35.1 to 40) had maximum preclinical abortions 20 (33%) 
in comparison to younger age group {(A);6(10%)}.The 
failure to conception was detected to be 12%, 31%, 
30%and 27% in groups A, B, C and D respectively. No 
significant difference was observed in variables of body 
mass index, basal and peak hormones. AFC in age group 
D was significantly less (14.4±2.79) as compared to 
younger age groups (p<0.001). Table 2 shows ovarian 
responsiveness to stimulation in age groups. It was 
noticed that there was no statistical difference in number 
of oocytes in all age groups whereas mature and fertilized 
oocytes were less in group D as compared to group C 
(p<0.05). In addition to that, oocyte maturity and 
fertilization rate of females aged 35.1 to 40years (Group 
D) was lower than other groups; significantly low 
(p<0.05) as compared with group C. The association of 
oocyte maturity with female age is expressed in fig., 
which narrates a trend towards decline in oocyte maturity 
with increase in female age. 
 
DISCUSSION 
 
Female age, BMI, inheritance of OR, basal FSH and 
antral follicle count (AFC) have an impact on dosage and 
duration of drugs required for favorable number of 
oocytes, quality of embryo and hence its implantation of 
after ICSI. The number of AFC present in the ovary 
depends on the number of primordial follicles present 
(Muttukrishna et al., 2005). Although it represents 
number of remaining primordial pool in women and 
corresponds to the number of oocytes retrieved, there is 
still a debate on its influence on quality of oocyte and 
embryo quality and hence result of ICSI (Rehman et al., 
2015 b) According to our study, there was significant 
effect of age on AFC. Females up to 25years of age (A) 
had a higher AFC as compared to other age groups. 
 
Literature reveals decline of AFC with age by a number 
of studies done in different decades. AFC declared to be a 
reliable marker for OR (Ferraretti et al., 2011). A study 
by Gabrielle J. 
Table 1: Comparison of outcome after intracytoplasmic Sperm Injection in females of different age groups 
 
Group Female age Number (282) Non- pregnant (120) 
Preclinical 
abortion (61) 
Clinical 
pregnancies (101) 
A Up to 25 years 30 (11%) 14 (12%) 6 (10%) 10 (10%) 
B 25.1 to 30years 84 (30%) 37 (31%) 18 (29%) 29 (29%) 
C 30.1 to 35years 85 (30%) 36 (30%) 17 (28%) 42* (41%) 
D 35.1 to 40 years 83 (29%) 33 (27 %) 20 (33%) 20 (20%) 
 
Results of age groups compared on the basis of outcome of ICSI in terms of clinical Pregnancy, Preclinical Abortions and no 
conceptions. (Percentages in columns)   
 
Table 2: Comparison of ovarian responsiveness to stimulation in age groups 
 
 A Upto 25 years B 25.1 to 30years C 30.1 to 35years D 35.1 to 40 years 
Total number of injections 
required for stimulation  
56.71 ± 8.582 56.34 ± 8.193 58.1 ±11.206 57.35 ± 7.924 
Number of injections in one day 4.02 ± 0.676 3.94 ±0.612 4.05 ± 0.79 4.02 ± 0.604 
No of oocytes/patient 7.97 ±2.189 7.79 ±1.715 7.71 ± 1.419 7.48 ± 1.664 
No of oocytes Metaphase II 7.4 ± 2.372 7.19 ± 1.917 7.08 ± 1.74 7.01 ±2.081* 
No of oocytes fertilized 6.13 ± 1.833 5.98 ± 1.505 5.89 ± 1.397 4.90 ± 1.679* 
Oocyte_retrieval_rate 98.37 ± 3.329 99.2 ±2.481 98.96 ± 4.883 99.05 ± 3.169 
Oocyte maturity rate 92.64 ± 16.18 92.85 ± 16.617 94.52 ± 15.405 91.54 ± 21.202* 
Fertilization Rate  77.11 ± 12.301 77.4 ±13.642 78.92 ± 13.179 77.33 ± 17.949* 
  
Values expressed as Mean ± SD 
Groups compared by one way analysis of variance  
 p value <0.05  for comparison of group D with C 
 Oocyte retrieval rate (%) = Total number of follicles at ultrasound/number of oocytes retrieved × 100  
 Oocyte maturity rate(%) = Total number of metaphase II oocytes / Total number of oocytes retrieved × 100  
 Fertilization rate (%) = Total number of 2 pronuclei/ Total number of oocytes microinjected × 100  
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Scheffer et al. showed that the AFC by the age of 37 
reduces every year by 4.8% and with further increase in 
age AFC reduces by 11.7% (Scheffer et al., 1999). A 
prospective study that was conducted by Ming-Yang 
Chang et al. portrayed that women with lower AFC had 
higher rate of miscarriages (Chang et al., 1998). Our 
results are supported by a study done by Antonio La 
Marca et al which illustrated that there was linear 
decrease in AFC with increasing age (Marca et al., 2011). 
In our study, a decrease in number of retrieved oocytes 
was observed with advancement in maternal age. This is 
in contrary to work conducted by Mille r JE and Smith TT 
2001 in which no considerable differences in relation to 
number of recovered oocytes, maternal age and 
percentage of fertilized oocytes during ICSI was observed 
(Miller and Smith, 2001). 
 
Advancing maternal age did show a great impact on the 
number of pregnancies by our group. Silber SJ et al. 
conducted an investigation which proved that age of 
female had no significant effect on the number of 
successful pregnancies
 
(Silber et al., 1997). The rate of 
preclinical abortions in group D was considerably higher 
which is in contrary to the results of a study in which 
females undergoing fertilization by ICSI had similar rates 
of abortions irrespective of age (Ulug U et al., 2006). 
These results are supported by Staessen C. et al. which 
showed a higher number of pregnancy loss after assisted 
reproductive techniques (ART) with advancement of age 
(Staessen et al., 2004). 
 
This is a unicentric study with a very small sample size, 
however is the first study in Pakistan to draw evidence-
based attention on awareness of age on reproductive 
outcome. The information obtained will help the women 
to know about the failure of treatment procedures, 
spontaneous pregnancy loss and likelihood of 
chromosomal abnormalities with progressive ageing and 
postponement of treatment.  
 
 
Fig. 1:  Effect of age on maturity of oocytes.  
 
CONCLUSION  
 
Female age is the noteworthy variable that can be blamed 
for poor reproductive outcome as a result of changes that 
lead to failure of maturation of oocyte and fertilization 
after intracytoplasmic micro injection of spermatozoa.  
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